As an experienced trial attorney in various technology fields, Christopher's goal is not only to solve his clients' immediate, pressing problems, but to develop long-term relationships, getting to know his clients' businesses so he can meet their needs strategically and proactively, rather than reactively.
Christopher is a trial attorney and former chair of the life sciences litigation practice group, focusing primarily on patent actions stemming from the Hatch-Waxman Act. He has tried cases to verdict in both federal and state courts, as well as in several contested arbitration hearings.
Currently, Christopher focuses most of his practice on ANDA litigation, representing the generic drug industry. These litigations involve Paragraph IV litigation matters to support his generic client’s ultimate goal of bringing less expensive prescription drugs to the market under the Hatch-Waxman Act. His representation of generic pharmaceutical companies serves to help control the costs of healthcare by bringing inexpensive generic drugs to the market faster.
He has also represented patent holders and accused infringers in a wide variety of patent disputes, including internet method patents, precision fluid pumps, injection molded polycarbonate sunglass lenses, non-ANDA pharmaceutical composition disputes, electronic fuel injected two-stroke engines, air restriction indicators, load weighing software for surface mining machines, insulated concrete forms, and dog toys.
Prior to centering his practice on intellectual property litigation, Christopher focused his practice on fire litigation, which included complex product liability issues, construction litigation, and insurance coverage matters in a technologically complex area of a highly specialized legal field.
Christopher is the proud father of four great kids, considers himself an avid (but relatively unsuccessful) fisherman, and was the 1989 intramural darts champion at Montana State University in Bozeman, Montana, where he began his undergraduate studies.